Clinical Trial Update: A Study to Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee Replacement [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Dimolegin for prevention of thromboembolic complications during knee replacement is ongoing, with unknown current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Dimolegin (dimolegin)

Snippet

Sponsor: PharmaDiall Ltd. | Conditions: Venous Thromboembolism | Phase 2 | Status: UNKNOWN